The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes.

We have reported the association of variations in the activating protein-2beta (AP-2beta) transcription factor gene with type 2 diabetes. This gene was preferentially expressed in 3T3-L1 adipocytes in a differentiation stage-dependent manner, and preliminary experiments showed that subjects with the disease-susceptible allele showed stronger expression in adipose tissue than those without the susceptible allele. Thus, we overexpressed the AP-2beta gene in 3T3-L1 adipocytes to clarify whether AP-2beta might play a crucial role in the pathogenesis of type 2 diabetes through dysregulation of adipocyte function. In cells overexpressing AP-2beta, cells increased in size by accumulation of triglycerides accompanied by enhanced glucose uptake. On the contrary, suppression of AP-2beta expression by small interfering RNA inhibited glucose uptake. Enhancement of glucose uptake by AP-2beta overexpression was attenuated by inhibitors of phospholipase C (PLC) and atypical protein kinase Czeta/lambda (PKCzeta/lambda), but not by a phosphatidylinositol 3-kinase (PI3-K) inhibitor. Consistently, we found activation of PLC and atypical PKC, but not PI3-K, by AP-2beta expression. Furthermore, overexpression of PLCgamma enhanced glucose uptake, and this activation was inhibited by an atypical PKC inhibitor, suggesting that the enhanced glucose uptake may be mediated through PLC and atypical PKCzeta/lambda, but not PI3-K. Moreover, we observed the increased tyrosine phosphorylation of Grb2-associated binder-1 (Gab1) and its association with PLCgamma, indicating that Gab1 may be involved in AP-2beta-induced PLCgamma activation. Finally, AP-2beta overexpression was found to relate to the impaired insulin signaling. We propose that AP-2beta is a candidate gene for producing adipocyte hypertrophy and may relate to the abnormal characteristics of adipocytes observed in obesity.

[1]  R. Cardiff,et al.  Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression , 2003, Oncogene.

[2]  B. Gelb,et al.  Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. , 1999, Circulation.

[3]  Takaaki Hirai,et al.  Protein Kinase Cζ (PKCζ) : Activation Mechanisms and Cellular Functions , 2003 .

[4]  S. Ryu,et al.  The mechanism of phospholipase C-γ1 regulation , 2000, Experimental & Molecular Medicine.

[5]  B. Gelb,et al.  Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. , 2001, American journal of human genetics.

[6]  A. Newton,et al.  Regulation of protein kinase C ζ by PI 3-kinase and PDK-1 , 1998, Current Biology.

[7]  R. Buettner,et al.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. , 2000, Gene.

[8]  K. Siddle,et al.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.

[9]  R. Tjian,et al.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. , 1988, Genes & development.

[10]  R. Schüle,et al.  Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. , 1995, Development.

[11]  T. Bengtsson,et al.  alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway. , 2005, Endocrinology.

[12]  R. Jaenisch,et al.  Transcription factor AP-2 essential for cranial closure and craniofacial development , 1996, Nature.

[13]  D. James,et al.  Differential sorting of two glucose transporters expressed in insulin-sensitive cells. , 1991, The American journal of physiology.

[14]  A. Ullrich,et al.  Protein kinase C isoforms α, δ and θ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells) , 1998, Diabetologia.

[15]  S. Ryu,et al.  Inositol phospholipid-specific phospholipase C: complete cDNA and protein sequences and sequence homology to tyrosine kinase-related oncogene products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Morino,et al.  Protein-tyrosine Phosphatase-1B Negatively Regulates Insulin Signaling in L6 Myocytes and Fao Hepatoma Cells* , 2001, The Journal of Biological Chemistry.

[17]  S. Perrey,et al.  Sterol Regulatory Element-binding Protein-1 Is Regulated by Glucose at the Transcriptional Level* , 2000, The Journal of Biological Chemistry.

[18]  B. Gelb,et al.  Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus , 2000, Nature Genetics.

[19]  Y. Matsuzawa.  Adipocytokines and metabolic syndrome. , 2005, Seminars in vascular medicine.

[20]  Yan Liu,et al.  The gift of Gab , 2002, FEBS letters.

[21]  N. Webster,et al.  Insulin activates phospholipase C-gamma1 via a PI-3 kinase dependent mechanism in 3T3-L1 adipocytes. , 2001, Biochemical and biophysical research communications.

[22]  R. Somwar,et al.  An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes* , 1999, The Journal of Biological Chemistry.

[23]  Y. Terauchi,et al.  Molecular Mechanism of Insulin Resistance and Obesity , 2003, Experimental biology and medicine.

[24]  T. Sasaoka,et al.  Potential Role of Gab1 and Phospholipase C-γ in Osmotic Shock-Induced Glucose Uptake in 3T3-L1 Adipocytes , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  M. Lane,et al.  Derepression of the C/EBPα gene during adipogenesis: Identification of AP-2α as a repressor , 1998 .

[26]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[27]  Yusuke Nakamura,et al.  Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus , 2005, Journal of Human Genetics.

[28]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[29]  D. S. Worrall,et al.  The osmotic shock-induced glucose transport pathway in 3T3-L1 adipocytes is mediated by gab-1 and requires Gab-1-associated phosphatidylinositol 3-kinase activity for full activation. , 2000, The Journal of biological chemistry.

[30]  M. Kasuga,et al.  Requirement of Atypical Protein Kinase Cλ for Insulin Stimulation of Glucose Uptake but Not for Akt Activation in 3T3-L1 Adipocytes , 1998, Molecular and Cellular Biology.

[31]  K. Morino,et al.  Membrane Localization of 3-Phosphoinositide-dependent Protein Kinase-1 Stimulates Activities of Akt and Atypical Protein Kinase C but Does Not Stimulate Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes* , 2002, The Journal of Biological Chemistry.

[32]  N. Webster,et al.  PLCgamma participates in insulin stimulation of glucose uptake through activation of PKCzeta in brown adipocytes. , 2002, Experimental cell research.

[33]  B. Spiegelman,et al.  ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose , 1999, Molecular and Cellular Biology.

[34]  J. Olefsky,et al.  Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes , 2004, Molecular and Cellular Biology.

[35]  A. Ullrich,et al.  Protein kinase C isoforms β 1 and β 2 inhibit the tyrosine kinase activity of the insulin receptor , 1997, Diabetologia.

[36]  P. Vollenweider,et al.  Association of the Insulin Receptor with Phospholipase C-γ (PLCγ) in 3T3-L1 Adipocytes Suggests a Role for PLCγ in Metabolic Signaling by Insulin* , 1998, The Journal of Biological Chemistry.

[37]  Khan Ah,et al.  Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. , 2002 .

[38]  H. Maegawa,et al.  Regulation of ATP-sensitive Potassium Channel Subunit Kir6.2 Expression in Rat Intestinal Insulin-producing Progenitor Cells* , 2005, Journal of Biological Chemistry.

[39]  L. Pirola,et al.  Modulation of insulin action , 2004, Diabetologia.

[40]  A. Wells,et al.  A role for phospholipase C activity in GLUT4-mediated glucose transport. , 1997, Endocrinology.

[41]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Ebina,et al.  Platelet-derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through phosphatidylinositol 3-kinase binding sites on the receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Rhee,et al.  Regulation of Phosphoinositide-specific Phospholipase C Isozymes* , 1997, The Journal of Biological Chemistry.

[44]  Y. Hayashizaki,et al.  Cloning and Characterization of a Novel Mouse AP-2 Transcription Factor, Ap-2δ, with Unique DNA Binding and Transactivation Properties* , 2001, The Journal of Biological Chemistry.

[45]  T. Pawson,et al.  Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1. , 1993, Oncogene.

[46]  C. Limatola,et al.  Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. , 1994, The Biochemical journal.

[47]  K. Heidenreich,et al.  Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity. , 2005, Endocrinology.

[48]  B. Goldstein,et al.  Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases , 1998 .

[49]  H. Pownall,et al.  Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase-alpha enhances lipid storage in cellular models of adipose tissue and skeletal muscle. , 2001, Diabetes.

[50]  J. Woodgett,et al.  Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. , 1998, The Biochemical journal.

[51]  C. A. Fick,et al.  Evidence for the involvement of a phospholipase C--protein kinase C signaling pathway in insulin stimulated glucose transport in skeletal muscle. , 2003, Life sciences.

[52]  E. Fuchs,et al.  Molecular cloning and characterization of AP-2ε, a fifth member of the AP-2 family , 2003 .

[53]  J. Hsuan,et al.  A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. , 1996, Oncogene.

[54]  T. Hirano,et al.  Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2 , 2003, Oncogene.

[55]  M. Sliwkowski,et al.  Blockade of Epidermal Growth Factor- or Heregulin-Dependent ErbB2 Activation with the Anti-ErbB2 Monoclonal Antibody 2C4 Has Divergent Downstream Signaling and Growth Effects , 2004, Cancer Research.

[56]  H. Sone,et al.  Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. , 2004, Diabetes.

[57]  J. Olefsky,et al.  Protein Phosphatase-2Cα as a Positive Regulator of Insulin Sensitivity through Direct Activation of Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes* , 2004, Journal of Biological Chemistry.